‘New frontier’: International workshop to explore non-coding RNAs in chronic disease

MicroRNAs and other non-coding RNAs are involved in almost every cellular process imaginable. They are also linked to many chronic diseases, including cancer, heart failure, diabetes, and neurological diseases. As such, these RNAs are also becoming targets for drug discovery, and the drugs are rapidly entering clinical trials. 

Biomedical researchers at Committee on Institutional Cooperation universities along with researchers affiliated with CAPES, a unit within Brazil’s Ministry of Education, will delve into current research on microRNAs and non-coding RNAs from April 30-May 2 at an international research workshop at Ohio State. The event will bring together scholars from eight CIC universities, including Ohio State, Indiana, Michigan State, Iowa, Michigan, Minnesota, Nebraska and Rutgers, along with five Brazilian research institutions.

Ohio State’s president, Dr. Michael V. Drake, along with the president of CAPES, Dr. Jorge Almeida Guimarães, a biomedical scholar, will launch the conference on Thursday, April 30, at 4:30 p.m. Dr. Carlo Croce, a leading authority on cancer research and microRNAs, will deliver the keynote, “MicroRNAs and Cancer.” On Friday, May 1, and Saturday, May 2, scholars will explore non-coding RNAs in chronic diseases as well as their biogenesis and function. Discussions will follow each panel, and these morning sessions are open to interested parties.

For conference information, including free registration, program and contacts, click here.—Center for Muscle Health and Neuromuscular Disorders, Ohio State